Barcode sequence could be a good target for developing a species‐specific anti‐parasite agent based on CRISPR‐Cas9. Issue 7 (31st May 2020)

• Record Type: Journal Article
• Authors: Pan, Yinlai; Sun, Yulong; Wang, Yilei; Zhang, Ziping
• Is Part Of: FASEB journal. Volume 34:Issue 7(2020)
• Page Start: 9393
• Page End: 9404
• Publication Date: 2020-05-31
• Subjects: CRISPR‐Cas9 -- Cryptocaryon irritans -- DNA barcode -- quantitative real‐time PCR -- species‐specific anti‐parasitic drug; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202000118RR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Parasitic infections are a severe issue in many regions of the world. We assume that if a chemical can destroy a DNA barcode sequence, then this chemical could be developed as a species‐specific parasiticidal agent. To test this hypothesis, we designed sgRNAs that target the sequences of both a DNA barcode (ITS‐2) and a control (5.8S rDNA) in Cryptocaryon irritans . In in vivo tests, we found that exposure to Cas9 mRNA mixed with sgRNAs was able to significantly reduce the hatching rate of tomont and the survival rate of theront. Quantitative Real‐time PCR demonstrated that the DNAs of tomont and theront exposed to sgRNAs and Cas9 mRNA were significantly disrupted, no matter whether they were exposed to a single sgRNA or a mixture of two sgRNAs. DNA sequencing also suggested the test group that was exposed to a single sgRNA mixed with Cas9‐induced mutation at sgRNA targeted fragments and the test group exposed to two sgRNAs combined with Cas9‐induced deletion of large pieces. The findings and principles provided by this study contribute to the development of novel nucleic acid therapeutic drugs for cryptocaryoniasis and other parasitic diseases and provide insight into the development of species‐specific parasiticidal agents.